MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MANNATECH INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.74+1.62 (+22.67%)
Close on Oct 19, 2026
- Market cap
- $16.87M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
7.9%
0M of 2M shares
Institutional holders
16
2 new, 4 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
3 buys · 0 sales
Net bought $62.16K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Toth Robert | 99,254 | 5.10% | 13D (active) | Jan 2, 2026 |
| Marlin Ray Robbins | 96,362 | 5.10% | 13G (passive) | Jun 14, 2022 |
| Lacore Terry | – | – | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MTEX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 52,163 | 2.70% | $271.77K | – | 0.00% |
| Vanguard Capital Management LLC | 41,528 | 2.15% | $216.36K | −8,089 | 0.00% |
| Renaissance Technologies LLC | 30,078 | 1.56% | $156.71K | −800 | 0.00% |
| IFG Advisory, LLC | 19,090 | 0.99% | $99.46K | New | 0.00% |
| Acadian Asset Management LLC | 4,690 | 0.24% | $24 | −3,051 | 0.00% |
| Vanguard Fiduciary Trust Co | 2,679 | 0.14% | $13.96K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 727 | 0.04% | $3.79K | +255 | 0.00% |
| Royal Bank of Canada | 316 | 0.02% | $2.00K | +236 | 0.00% |
| Vanguard Global Advisers, LLC | 250 | 0.01% | $1.30K | – | 0.00% |
| Wells Fargo & Company/Mn | 201 | 0.01% | $1.05K | +200 | 0.00% |
| UBS Group AG | 48 | 0.00% | $250 | −437 | 0.00% |
| National Bank Of Canada /Fi/ | 30 | 0.00% | $150 | – | 0.00% |
| SRS Capital Advisors, Inc. | 12 | 0.00% | $63 | – | 0.00% |
| Morgan Stanley | 2 | 0.00% | $15 | – | 0.00% |
| Citigroup Inc | 1 | 0.00% | $5 | New | 0.00% |
| SBI Securities Co., Ltd. | 1 | 0.00% | $5 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 16 | 0M | 7.9% | 2 / 3 | 4 / 4 | 0M | 0M |
| Q1 2026 | 18 | 0M | 9.6% | 5 / 3 | 5 / 5 | 0M | 0M |
| Q4 2025 | 19 | 0M | 10.8% | 2 / 4 | 7 / 4 | 0M | 0M |
| Q3 2025 | 21 | 0M | 11.5% | 2 / 6 | 5 / 2 | 0M | 0M |
| Q2 2025 | 21 | 0M | 11.3% | 2 / 6 | 3 / 2 | 0M | 0M |
| Q1 2025 | 21 | 0M | 11.3% | 4 / 3 | 4 / 0 | 0M | 0M |
| Q4 2024 | 17 | 0M | 10.3% | 4 / 2 | 4 / 1 | 0M | 0M |
| Q3 2024 | 14 | 0M | 12.0% | 1 / 2 | 4 / 3 | 0M | 0M |
| Q2 2024 | 17 | 0M | 12.5% | 1 / 5 | 5 / 2 | 0M | 0M |
| Q1 2024 | 18 | 0M | 12.5% | 2 / 5 | 3 / 1 | 0M | 0M |
| Q4 2023 | 17 | 0M | 12.5% | 1 / 6 | 4 / 5 | 0M | 0M |
| Q3 2023 | 21 | 0M | 22.7% | 2 / 2 | 5 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of MTEX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 31,432 | 1.63% | $163.76K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 7,400 | 0.38% | $38.55K | 0.00% | Jun 30, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 5,566 | 0.29% | $29.00K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 4,495 | 0.23% | $25.62K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 2,696 | 0.14% | $14.05K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 1,681 | 0.09% | $9.58K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 1,393 | 0.07% | $7.94K | 0.00% | May 31, 2026 |
| U.S. Targeted Value Portfolio | 969 | 0.05% | $4.64K | 0.00% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 422 | 0.02% | $2.41K | 0.00% | May 31, 2026 |
| Dimensional U.S. Targeted Value ETF | 164 | 0.01% | $786 | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yasir Haider | Chief Financial Officer | – | – | Jun 18, 2026 |
| James Clavijo | Chief Financial Officer | – | – | Aug 28, 2025 |
| Landen Granvel Fredrick | President and CEO | 3,975 | 0.21% | Aug 28, 2025 |
| Erin Kemmler Barta | General Counsel | 3,000 | 0.16% | Aug 28, 2025 |
| Seifrick A. John | Director | 13,746 | 0.71% | Jun 5, 2026 |
| Robert Toth | Director | 95,920 | 4.97% | Jun 5, 2026 |
| Larry A. Jobe | Director | 70,000 | 3.63% | May 21, 2026 |
| Kevin Andrew Robbins | Director | 33,333 | 1.73% | May 20, 2026 |
| J. Stanley Fredrick | Director | 1,611,765 | 83.53% | Jan 6, 2026 |
| Tyler Rameson | Director | 306,673 | 15.89% | Jan 6, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Larry A. Jobe Director | May 20, 2026 | Buy | +2,803 | $4.12 | $11.55K | 70,000 |
| Kevin Andrew Robbins Director | May 19, 2026 | Buy | +7,100 | $4.17 | $29.61K | 33,333 |
| Larry A. Jobe Director | May 19, 2026 | Buy | +5,000 | $4.20 | $21.00K | 67,197 |
| Robert Toth Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 95,920 |
| Tyler Rameson Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 306,673 |
| J. Stanley Fredrick Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 361,765 |
| Larry A. Jobe Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 62,197 |
| Seifrick A. John Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 13,746 |
| Kevin Andrew Robbins Director | Jan 2, 2026 | Award | +4,790 | $8.35 | $40.00K | 26,233 |
| Larry A. Jobe Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 57,407 |
| J. Stanley Fredrick Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 356,975 |
| Robert Toth Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 91,130 |
| Seifrick A. John Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 8,956 |
| Tyler Rameson Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 301,883 |
| Kevin Andrew Robbins Director | Jan 2, 2025 | Award | +2,686 | $14.89 | $39.99K | 21,443 |
| Larry A. Jobe Director | Sep 9, 2024 | Sale | −16,288 | $7.75 | $126.23K | 54,721 |
| Tyler Rameson Director | Sep 9, 2024 | Buy | +16,288 | $7.75 | $126.23K | 299,197 |
| Larry A. Jobe Director | May 22, 2024 | Sale | −1,012 | $7.60 | $7.69K | 71,009 |
| Landen Granvel Fredrick COO/Interim CFO | Mar 11, 2024 | Award | +8,187 | $9.16 | $74.99K | 12,162 |
| J. Stanley Fredrick Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 354,289 |
| Kevin Andrew Robbins Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 18,757 |
| Tyler Rameson Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 282,909 |
| Seifrick A. John Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 6,270 |
| Larry A. Jobe Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 72,021 |
| J. Stanley Fredrick Director | Jan 2, 2024 | Award | +4,932 | $8.11 | $40.00K | 229,289 |
| Alfredo Bala CEO and President | Aug 30, 2023 | Sale | −1,000 | $12.40 | $12.40K | 3,137 |
| Larry A. Jobe Director | Aug 18, 2023 | Sale | −1,217 | $12.82 | $15.60K | 67,089 |
| Alfredo Bala CEO and President | Jun 30, 2023 | Sale | −115 | $12.62 | $1.45K | 4,137 |
| Alfredo Bala CEO and President | Jun 29, 2023 | Sale | −154 | $12.89 | $1.99K | 4,252 |
| Landen Granvel Fredrick Chief Sales/Marketing Officer | Feb 14, 2023 | Option exercise | +2,000 | $5.72 | $11.44K | 3,975 |
| J. Stanley Fredrick Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 224,357 |
| Larry A. Jobe Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 68,306 |
| Seifrick A. John Director | Jan 3, 2023 | Award | +1,338 | $17.43 | $23.32K | 1,338 |
| Robert Toth Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 88,444 |
| Kevin Andrew Robbins Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 13,825 |
| Tyler Rameson Director | Jan 3, 2023 | Award | +2,294 | $17.43 | $39.98K | 277,977 |
| Alfredo Bala CEO and President | Dec 21, 2022 | Sale | −3,500 | $19.69 | $68.92K | 4,406 |
| Kevin Andrew Robbins Director | Dec 8, 2022 | Sale | −1,500 | $22.00 | $33.00K | 11,531 |
| Kevin Andrew Robbins Director | Mar 28, 2022 | Sale | −1,100 | $36.57 | $40.23K | 13,031 |
| J. Stanley Fredrick Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 222,063 |
| Tyler Rameson Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 275,683 |
| Larry A. Jobe Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 66,012 |
| Kevin Andrew Robbins Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 14,131 |
| Eric W. Schrier Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 19,118 |
| Robert Toth Director | Jan 3, 2022 | Award | +1,012 | $39.49 | $39.96K | 86,150 |
| Alfredo Bala CEO and President | Nov 30, 2021 | Tax withholding | −2,724 | $35.97 | $97.98K | 7,906 |
| Alfredo Bala CEO and President | Nov 30, 2021 | Option exercise | +5,000 | $19.60 | $98.00K | 10,630 |
| Erin Kemmler Barta General Counsel | Nov 29, 2021 | Option exercise | +3,000 | $5.72 | $17.16K | 3,000 |
| Alfredo Bala CEO and President | Nov 29, 2021 | Option exercise | +1,150 | $15.70 | $18.06K | 5,630 |
| David Allen Johnson Chief Financial Officer | Nov 23, 2021 | Option exercise | +12,500 | $15.70 | $196.25K | 12,500 |
| Ronald Dale Norman Sr VP Treasury | Sep 7, 2021 | Option exercise | +5,000 | $5.72 | $28.60K | 6,030 |
| Robert Toth Director | Sep 1, 2021 | Option exercise | +3,333 | $16.93 | $56.43K | 85,138 |
| Robert Toth Director | Sep 1, 2021 | Option exercise | +5,000 | $19.60 | $98.00K | 81,805 |
| Eric W. Schrier Director | Aug 30, 2021 | Tax withholding | −5,218 | $33.89 | $176.84K | 18,106 |
| Eric W. Schrier Director | Aug 30, 2021 | Option exercise | +5,000 | $21.18 | $105.90K | 23,324 |
| Eric W. Schrier Director | Aug 30, 2021 | Option exercise | +5,000 | $14.19 | $70.95K | 18,324 |
| Kevin Andrew Robbins Director | Aug 26, 2021 | Option exercise | +5,000 | $17.28 | $86.40K | 13,119 |
| J. Stanley Fredrick Director | Aug 24, 2021 | Option exercise | +5,000 | $5.72 | $28.60K | 221,051 |
| Kevin Andrew Robbins Director | Aug 23, 2021 | Sale | −1,500 | $32.99 | $49.49K | 8,119 |
| Kevin Andrew Robbins Director | Aug 20, 2021 | Sale | −1,000 | $32.24 | $32.24K | 9,619 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Bala Alfredo Officer | Sep 27, 2024 | 1,607 | $12.21K | Sep 27, 2024 | Incentive Stock Option |
| Bala Alfredo Officer | Jul 19, 2024 | 1,500 | $21.75K | Jul 19, 2024 | Incentive Stock Option |
| Bala Alfredo Officer | Aug 29, 2023 | 1,000 | $22.34M | Aug 29, 2023 | Incentive Stock Option |
| Bala Alfredo Officer | Jun 29, 2023 | 1,000 | $12.80K | Jun 29, 2023 | Incentive Stock Option |